The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, December 01, 2022
Roivant Sciences and Pfizer Inc. announced formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101). RVT-3101 is a fully human ...
read more
Thursday, December 01, 2022
Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-...
read more
Friday, December 02, 2022
Eli Lilly and Company announced the successful completion of its acquisition of Akouos, Inc. The acquisition expands Lilly's efforts in genetic ...
read more
Tuesday, December 06, 2022
For over 25 years BRANDTECH Scientific, Inc. has represented the BRAND Group as the US and Canadian supplier of dependable, high-quality laboratory ...
read more
Tuesday, December 06, 2022
Roche announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.
read more
Wednesday, December 07, 2022
The FDA is announcing the availability of a revised draft guidance for industry, ANDAs: Pre-Submission Facility Correspondence Related to Prioritized ...
read more
Thursday, December 08, 2022
Moleculin Biotech announced that the FDA granted Fast Track designation of WP1122 for the treatment of Glioblastoma Multiforme ("GBM").
read more
Monday, December 12, 2022
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the FDA for talquetamab...
read more
Monday, December 12, 2022
Pfizer Canada ULC and BioNTech SE announced that Health Canada has authorized COMIRNATY® Original & Omicron BA.4/BA.5 as a 10-µg booster dose for ...
read more
Monday, December 12, 2022
The U.S. Pharmacopeia (USP) announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a ...
read more
Tuesday, December 13, 2022
ADMA Biologics, Inc. announced the FDA approval for its supplemental Biologics License Applications (BLAs) for both ASCENIV and BIVIGAM to now include...
read more
Wednesday, December 14, 2022
Takeda will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being ...
read more
Thursday, December 15, 2022
Discovery Life Sciences™ announced the launch of its new Proteomic Services Division and is now accepting samples from pharmaceutical and biotech ...
read more
Friday, December 16, 2022
AbbVie has submitted a supplemental New Drug Application (sNDA) for linaclotide (LINZESS®) FDA to treat children and adolescents 6 to 17 years of age ...
read more
Friday, December 16, 2022
Now in its 20th year! The bioindustry's most in-depth, global benchmarking and analysis study: Your input is important as we benchmark current global ...
read more